Invitation to presentation of Xbrane Biopharma’s interim report January – June 2024 on August 28, 2024

Xbrane Biopharma AB invites to a teleconference for investors, analysts and media on Wednesday, August 28th, 2024, at 13.00 a.m. CET. Xbrane will publish the company’s interim report January – June 2024, on Wednesday, August 28, 2024, at 8.00 a.m. CET.

Martin Åmark, CEO, and Anette Lindqvist, CFO/IR, will present the interim report January – June 2024, followed by a Q&A session. The presentation will be in English. To attend, please follow the link below:

If you wish to participate via webcast, please use the link below. Via the webcast you can ask written questions.

Xbrane Biopharma Q2 Report 2024 (financialhearings.com)

If you wish to participate via teleconference, please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.

Call Access (financialhearings.com)

Datum 2024-08-23, kl 14:00
Källa MFN
Ungdomsdeal - 200 kr ! Just nu får alla nya kunder mellan 18 och 25 år 200 kr gratis när man skapar konto på Nordnet, insatt i fonden Nordnet One Balanserad. Bra läge att testa Nordnet!
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet